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Abstract
Background: Cardio-metabolic syndrome (CMS) is a highly prevalent condition. There is an urgent need to identify
effective and integrated multi-disciplinary approaches that can reduce risk factors for CMS.
Methods: Sixty-two patients with a history of CMS were randomized 1:1 into two groups: a standard information
-only group (control), or a self-regulated lifestyle waist circumference (patient-centered cognitive behavioral
therapy) intervention group. A pretest and posttest, controlled, experimental design was used. Outcomes were
measured at the baseline (week 0) and at the end of intervention (week 12). Comparisons were drawn between
groups and over time.
Results: The mean (standard deviation) age of the subjects was 48.6 (5.8) years ranging from 32 to 63, and 56.9%
of the participants were female. Both groups showed no significant differences in Demographic variables and the
metabolic syndrome indicators at baseline. While the control group only showed modest improvement after
12 weeks, compared to baseline, the intervention group demonstrated significant improvement from baseline. This
study controlled for patients’ demographics and baseline characteristics when assessing the effects of intervention.
After adjusting for age, education and baseline level, the experimental group and the control group were statistically
significant different in the following post-treatment outcomes: WC (F = 35.96, P< 0.001), TG (F = 18.93, P< 0.001), RSBP
(F = 33.89, P < 0.001) and SF-36(F = 157.93, P < 0.001). The results showed patients’ age and education were not strong
predictors of patients’ outcome (including WC, TG, RSBP and SF-36).
Conclusions: Lifestyle intervention on patient-centered cognitive behavioral therapy can improve the physical and mental
health conditions among individuals reporting a history of cardio-metabolic syndrome, and possibly provided preliminary
benefits for the treatment of CMS.
Trial registration: Chinese Clinical Trial Register #, ChiCTR15006148.
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Background
Associated with the rapid economic growth, life style
changes, and the aging population, cardio-metabolic syn-
drome (CMS) is becoming increasingly prevalent in
China [1, 2] and worldwide [3]. CMS, also called the
“deadly quartet”, is characterized by the presence of cen-
tral obesity (also known abdominal or visceral obesity),
dyslipidemia, diabetes, and hypertension. Every condi-
tion is also a risk factor for cardiovascular disease(CVD)
and associated with low quality of life [4, 5]. Central
obesity is the typical representation [6]. Most risk factors
of CMS including overweight, no exercise, irregular
sleep, unhealthy diet, and smoking,also related to the
level of psychological stress [7] and the extent of mor-
bidity [8].
Developing effective interventions to decrease the risk
of CMS is critical for public health. Unhealthy lifestyle is
one of the most significant public health problems in the
21st century [9, 10]. Developing good behavioral habits
and maintaining balanced psychological state are neces-
sary for people’s overall health [11]. According to the
World Health Organization, an 'unhealthy lifestyle' is de-
fined as the failure to achieve the minimum recom-
mended physical fitness exercises (i.e., for adults,
150 min of moderate aerobic exercise or 75 min of vig-
orous aerobic exercise per week, or an equivalent com-
bination). However, at least 60% of the global population
fail to meet the standard [12].
To achieve optimum effectiveness, cognitive behavioral
therapies are designed to concentrate on changing the
patient’s negative cognitive habits and emotion, and re-
structuring the healthy thinking patterns and promoting
positive feelings. The ultimate goal is to change the pa-
tients’ lifestyle and health-related behaviors. In addition,
this therapy lets the participants to be their own thera-
pists [13] in order to effectively control their lifestyle
and prevent chronic disease [14]. Lifestyle modification
based on cognitive behavior therapy is an essential com-
ponent of the comprehensive approach to manage the
CMS. Effective lifestyle intervention to increase health
benefits is considerably important, and cognitive behav-
ioral procedures represent additional nonsurgical inter-
vention for reducing the risk of CMS.
To address the poor adherence [15], the longer-term
therapy generally requires a partnership with the patients
[16]. A growing body of literature explores using patient-
centeredness and shared clinical decision-making to im-
prove treatment outcomes for people with chronic dis-
eases [17]. “Patient-centeredness” puts the patient’s needs
the foremost when addressing their disease issues. “Pa-
tient-centered” communication is a behavior intervention
approach that elicits, respects and incorporates patients’
wishes and allows active patient participation [18]. Shifts
from the biomedical, paternalistic model to more patient-
centeredness suggests the efforts should focus on deliver-
ing belief that incorporates patients’ needs, preference,
goals, will, and paying attention to their decisions when
providing reasonable medical treatment [19, 20].
Behavioral health presents psychology and its sister
professions with new opportunities for training, re-
search, and practice [21]. In the last few years’ studies
have demonstrated beneficial effects of interdiscipinary
approach combining exercise and healthy diet for the
treatment of obesity [22] and MS [23], lifestyle interven-
tions can be observed from a combination approach,
such as exercise and patient-centered cognitive behav-
ioral therapy in both depression and type 2 diabetes out-
comes [24], and low-energy-density dietary counseling
and cognitive behavioral therapy for obesity and binge
eating disorder [25].
We suggest that patient-centered cognitive behavioral
therapy emphasizes integrated care, putting patients
first, improving patients’ cognitive, emotional and beha-
viorial styles,and further accept and conform healthy
lifestyles. In the present study, 127 adults with CMS
were randomized to further study the effectiveness of
lifestyle intervention offered by a 12-week patient-
centered cognitive behavioral therapy on health indica-
tors and quality of life among participants with CMS.
The lifestyle intervention of patient-centered cognitive
behavioral therapy (PC-CBT) constructs incorporated
shared clinical decision, supervised exercise sessions,
dietary education and advice, advice for the smoking
cessation, and the promotion of lifestyle behavioral
change using Skinner’s behavior intensified techniques.
We hypothesized that the intervention should decrease
the risk of CMS, and increase the patients’ quality of life
when compared with the advice-only control approach.
Methods
Participants
At enrollment, all volunteers agreed in written form to
provide their data anonymously and receive necessary
treatment provided by their doctors. Eligible patients
were at least 18 years of age, and metabolically affected
by the CMS. The cardio-metabolic syndrome was de-
fined using the 2005 IDF (international diabetes founda-
tion) recommendations: waist circumference (primarily
based on the epidemiological data of Shanghai and Hong
Kong) [26]) ≥ 90 cm for males and ≥ 80 cm for females,
fasting serum-triglyceride levels of ≥ 1.7 mmol/L, blood
pressure ≥ 130/85. All participants were able to read and
understand Chinese, which was the language of the
questionnaire. Patients who could not adhere to treat-
ment during the intervention period because of their
physical conditions, mental state or other reasons deter-
mined by a physician were excluded. The research was
approved by the Institutional Review Board (IRB) of the
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Jinzhou medical university affiliated hospital. All on-
going and related trials of this intervention are
registered.
Main outcome measurement
Socio-demographic characteristics concerning age, gen-
der, employment status, marital status, level of education
were obtained from all patients, and concurrent medica-
tion uses were also recorded by the researcher. Life style
information before and after the intervention was also
collected. Outcome measurements included in this study
were: waist circumference, fasting serum-triglycerides
levels, resting systolic blood pressure, and health-related
quality of life. The TG levels were collected from the
participant’s latest three months clinic records. The
waist circumference (WC) was measured in a standing
position at the midpoint between the lowest rib and the
iliac crest at the late exhalation.
The quality of life was based on a 36-item short form
of health survey (SF-36). SF-36 includes 8 scales and 36
items: physical functioning (PF, 10 items), physical role
functioning (RP, 4 items), bodily pain (BP, 2 items), gen-
eral health perceptions (GH, 5 items), mental health
(MH, 5 items), social functioning (SF, 2 items), emo-
tional role functioning- (RE, 3 items), vitality (VT, 4
items), and health transition (HT, 1 item). Physical and
mental health summary scores are derived from the
eight scales. Higher percentile scores represent a better
quality of life.
Procedures and setting
Volunteers were recruited from Jinzhou, a regional city
in Northeastern China. The study protocol was approved
by the Human Research Ethics Committee at the first af-
filiated hospital of Jinzhou Medical University (KY
201407) on December 18th 2014. Data were collected
between April 2015 and November 2015. Recruitment
was conducted through the distribution of flyers in the
community calling for volunteers to participate in the
PC-CBT lifestyle intervention trial which was aimed at
changing people’s lifestyle habits to reduce CMS risk fac-
tors and improve their health condition All participants
understood the study and gave their written informed
consent before he/she was enrolled in the lifestyle work-
shop curriculum. Then participants were randomly
assigned to receive the lifestyle intervention using PC-
CBT constructs or “consultation only” (control). The in-
dividual participant’s assignments were sealed in serially
numbered envelopes. The whole laboratory analyses
were conducted by technicians blinded to treatment as-
signment. Participants and investigator were not blinded
because of the nature of the treatment.
Intervention
Twenty-four workshops were conducted for the inter-
vention group. In contrast to the control group, volun-
teers in the “PC-CBT” group received several workshops
developed for lifestyle change based on patients-
centered cognitive behavioral therapy. The workshop
was offered 2 days per week for a group of minimum
five patients. It consists of eight modules, each lasts 90–
120 min. The content of the workshop is largely based
on global guidelines and the PC-CBT constructs but
some modules include condition-specific contents. The
workshop contents are shown in Table 1.
A psychologist and an internal medicine physician led
the workshop. For some modules an old CMS patient
with a chronic condition and a clinician specialized in
geriatrics were invited as experts. Group leaders estab-
lished good relationships with the patients. Based on a
standardized interview questionnaire [27], patients were
asked about their opinions regarding lifestyle interven-
tion options such as being conscious about their health,
or being persistent on exercise. To attain feasible life-
style goals, we considered patients’ specific circum-
stances, individual preferences, needs and values, and
ensured that patients’ values directed all clinical deci-
sions [28]. Therapists applied shared decision-making
according to patients specific condition and value sys-
tem. Both therapists and patients were involved in mak-
ing the goals for the lifestyle change, and therapists also
educated the participants on CMS as a chronic disease,
the need for self-determination program, and the im-
portance of cooperation with clinicians. The objective of
the patient-centered discussion is to let the patient
understand how the lifestyle change is generally taking
place and accept the concept of healthy behavior accord-
ing to individual’s condition.
The behavioral reinforcement component of the inter-
vention was integrated into the healthy lifestyle session
and was based on Watson's operational behavior reflec-
tion theory. Meditation was also required as described in
the broad spectrum cognitive-behavioral therapy [29].
Concurrent psychological cognitive-behavioral therapy
such as stress management training, and abdominal
breathing were also integrated into these sessions. The
aim was to modify and maintain participants’ healthy be-
havior and being more conscious about their health.
Such approach has demonstrated efficacy in clinical pop-
ulations previously [30, 31].
Lifestyle modification program was individualized after
considering the attitude of the participants [32]. Partici-
pants were empowered to independently develop a life-
style change program based on shared decision-making
process. Patients were also guided and encouraged to
adopt and maintain 150 min of medium exercise per
week, a 200–300 kcal reduction in daily dietary calories
Zhang et al. BMC Cardiovascular Disorders  (2016) 16:227 Page 3 of 9
[33], do not stay up late, quit smoking and limit alcohol
consumption. Patients were guided and encouraged to
develop new recipes to increase the intake of high qual-
ity food that are rich in protein, potassium and calcium.
Furthermore, patients were encouraged to reduce fat in-
take and consume more fruit and vegetables, and alter
night-time snack eating habits. Exercise activities such as
walking, where the patients could be accompanied by a
relative or friend, were especially encouraged. Individual-
ized recommendations on lifestyle change were made to
be feasible and practical.
Control group
Participants allocated to the advice-only control group
received a letter explaining their group allocation and
basic lifestyle advice and general information about
CMS risk factors. They were sent weekly text messages
about the standard care for CMS. There were no in per-
son contacts with the control group during the study
other than the scheduled measurements.
Statistical analysis
Analysis of the data from this study was performed using
SPSS 21.0 statistical software (SPSS, IBM, Lmd, Beijing,
China). We attempted to establish the clinical signifi-
cance of the lifestyle intervention on PC-CBT constructs
in the treatment of cardio-metabolic syndrome using a
pre- and post-test equivalent group design. All analyses
presented here are based on data from subjects who
completed the 12-weeks study. To validate these results,
additional calculations were performed by replacing all
missing data with baseline data, according to the “base-
line observation carried forward” method [34].
Outcome measurements were assessed at baseline be-
fore randomization (week 0) and at the end of the inter-
vention (week 12). Mean and standard deviations are
used to describe the baseline characteristics and post-
treatment status for continuous variables. Statistical ana-
lysis of the outcome differences between the groups,
after 12 weeks, was performed using a Student's t test.
Categorical variables are presented as frequencies and
percentages. The differences were considered statistically
significant when the p value is < 0.05 (two-tailed). Gen-
eral linear regression was used to analyze the treatment
effect, adjusting for differences on baseline characteris-
tics (age, marriage status, education level, and employ-
ment state) and baseline levels of WC, TG, RSBP and
SF-36 total.
Results
Study population and patients characteristics
A total of 127 patients with CMS were identified, and
83(65%) were qualified for study criteria. Of those, 62
expressed interest in participating along with the survey
and were randomized into 2 groups: the 12-week PC-
CBT, and standard lifestyle consultation-only. During
the study, 58 patients (28 and 30 in the PC-CBT or con-
trol groups, respectively) had complete follow-up
(93.5%). Figure 1 shows the patients enrollment and
follow-up throughout the study.
The mean age of the CMS patients was 48.6 years (SD =
5.8; range = 32–63) with 56.9% of the patients above
50 years. The majority of patients were female (56.9%).
Most people were married and living together with partners
(63.8%). One third of the participants (34.5%) held a degree
or post graduate qualification and 39% were employed full-
time. The average duration of CMS from diagnosis was 9.6
(SD = 3.2) years. Clinically, most patients were considered
to be obese (63.8%) and 55.2% had hypertension.
SF-36 reliability analysis
The scores obtained from the patients completed the
SF-36 survey were converted to a percentile score. In
this study, SF-36 had a cronbach alpha value of 0.899.
The alpha coefficients for the two sub-scales (Physical
Health and Mental Health) were 0.845 and 0.836, re-
spectively. These values conform to the measurement
requirements.
Baseline characteristics
In order to confirm that the 58 participants who com-
pleted this study in the intervention and control groups




Module 1: break ice Welcome, introduce each other, subjects
overview
Module 2: interaction with
each other deeply
Acquaintance each other, talking about
their own families, work if have one,
tailoring communication to preferences,
needs and values, discussing differences
Module 3: talking about
health
Communication about CMS, challenge and
opportunities, sharing of illness related
fears and concerns, risk assessment
Module 4: talking about
lifestyle
Methods in health regulation, exercise,
eating habit, and so on
Module 5: methods in
psychology adjustment
CBT, behavioral reinforcement, meditation,
stress management, and abdominal
breathing
Module 6: patient-centered Shared-clinical decision-making scheme,
self-deterrnination theory, participant atti-
tude, awareness of being responsible for
their own health
Module 7: viable lifestyle
change program
Reasonable diet and exercise, don’t stay up
late, eliminate smoking, limit alcohol
consumption, night-time snack eating
habits
Module 8: close Planning of personal goal, close
Note: CMS cardio-metabolic syndrome, PC-CBT patient-centered cognitive
behavioral therapy
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were comparable, we compared their lifestyle factors,
biomarker levels, SF-36 and relevant comorbidities at
baseline (Table 2). No significant differences were
found for WC and TG, and SF-36 characteristics be-
tween two groups (except a borderline significant dif-
ference in RSBP value (p = 0.03) which was higher in
the control group).
Comparisons of post-test indicators in control and PC-CBT
groups
Table 2 also shows the proportion of patients achieved
lifestyle targets and their CMS information before and
after the intervention in both intervention and control
groups. Participants in the intervention group achieved
smoking cessation, diet and physical activity targets.
Mental Health and Vitality in the health related life
quality changes over time were not significantly different
between groups (p = .133 & .303). Comparing to control
group, there was a lower decrease in the levels of CMS
biomarkers and also a marked increase in certain health
related life quality (physical functioning; role –physical;
bodily pain; general health; social functioning; role-
emotional; health transition) in the intervention group.
The effect of PC-CBT lifestyle intervention on the cardio-
metabolic syndrome
We adjusted patients’ age, education, and baseline waist
circumference, blood pressure, fasting serum-triglyceride
levels and the SF-36 scores in GLM analysis.
The results showed that age and education were not
strong predictors of patients’ outcome (including WC,
TG, RSBP and SF-36). After adjusting for age, education
and baseline level, the experimental group and the control
group were statistically significant different in the follow-
ing post-treatment outcomes: WC (F = 35.96, P < 0.001),
TG (F = 18.93, P < 0.001), RSBP (F = 33.89, P < 0.001) and
SF-36(F = 157.93, P < 0.001) (See Table 3).
Post-test value shows that the waist circumference in fe-
male remains higher than the high risk threshold (>80).
Changes of waist circumferences from baseline and by
gender after the lifestyle intervention are shown in Fig. 2
and Fig. 3. Compared to the controlled group, the inter-
vention group showed significant decreases in WC (−7.9,
p < 0.001 in men and −8.0, p < 0.001 in women).
Discussion
This study evaluated the effect of PC-CBT lifestyle inter-
vention on cardio-metabolic syndrome. Patients ran-
domized to PC-CBT lifestyle intervention received self-
involved management, were introduced to routine exer-
cise and healthier diet, combined with psychological be-
havioral change program for 12 weeks. The intervention
was well received by the patients, represented by high
compliance rate (90.6%).
Individuals with obesity who participated in the
program of health dietary and regular exercise had re-
duced CMS risk over time, demonstrating the poten-
tial value of lifestyle intervention [35–37]. The critical
effect of psychological processes on the success of
lifestyle change suggests that new psychological and
patient-centeredness approach should be adopted in
the lifestyle intervention, to help CMS patients de-
velop their own favorite healthy lifestyle, and change
their old and unhealthy behavior. Combined together,
these approaches provide more hope for an effective
treatment of CMS [38].
The results of this study show that PC-CBT lifestyle
intervention leads to remarkable reductions in waist cir-
cumference, fasting serum-triglycerides levels, resting
systolic blood tension, and improved quality of life when
Fig. 1 Detailed flow of participants through the study
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compared to the control group. The magnitude of these
changes was significant and may be adequate to provide
clinical benefits. Waist circumference and CMS bio-
marker level reductions after PC-CBT lifestyle interven-
tion are typically greater than those without [39, 40]. A
possible explanation of the mechanism responsible for
this change is shared-clinical decision making, where the
responsibility for behavioral changes is transferred from
counselors to the patient.
Similarly, an effective CMS treatment strategy should
include the engagement of patients in determining
healthy lifestyles and maintaining the results also re-
quires specific strategies [41]. Patient-centered interven-
tion has been considered to be an indispensable element
of healthcare [42]. The concept of patient-centered
approach comprehensively combines the cognitive,
emotional and behavioral techniques. We think the
intervention that played a significant role is those con-
nected with patient-centeredness. Good relationship is
the basis of good clinical decision. The treatment plan
also considers individual’s personality, self-perception,
and health-centered consciousness. The other explan-
ation may be: shared-decision, self-determination and
the use of behavior intensifying techniques, which en-
hance the sense of self-control and self-efficacy in pa-
tients, which further enhanced inner motivation to keep
a healthy lifestyle [43].
Participants were self-reported at baseline as CMS.
We selected general indicators such as waist circumfer-
ence (central obesity), resting systolic blood tension, fast-
ing serum-triglycerides, as these are especially relevant
to the psycho-social aspects of CMS [44–46]. And we
Table 2 Raw data by group and P-value at baseline point and the end of intervention
Baseline characteristics The end of intervention
(week 0) (week 12)
All subjects Control Intervention P-value Control Intervention mean diff.(95% CI) P-value
Not smoking (N, %) 18(60) 16(57.1) 22(73.3) 24(85.7)
Saturated fat(≤10% of total energy)
(N, %)
14(46.7) 13(46.4) 18(60) 23(82.1)
Fruit and vegetables(≥400 g per day)
(N, %)
9(30) 10(35.7) 13(43.3) 22(78.6)
Physical activity(≥150 min per week)
(N, %)
11(36.7) 11(39.3) 16(53.3) 20(71.4)
WC total (cm) 94.2 ± 3.2 94.9 ± 2.8 93.4 ± 3.4 0.071 94.1 ± 2.8 86.0 ± 2.4 −8.1 (−9.5, −6.7) .000***
WC in men — 96 ± 2.4 94.6 ± 3.9 0.215 95.2 ± 2.4 87.3 ± 2.3 −7.9 (−9.6, −6.2) .000***
WC in women — 93 ± 2.5 92 ± 2.3 0.212 92.5 ± 2.8 84.5 ± 1.6 −8.0 (−9.9, −6.2) .000***
Cardio-metabolic
TG (mmol/L) 2.0 ± 0.4 2.1 ± 0.2 1.9 ± 0.5 0.127 1.9 ± 0.2 1.1 ± 0.3 −0.8 (−0.9, −0.7) .000***
RSBP (mmHg) 140.5 ± 3.4 140.0 ± 3.2 141.5 ± 3.3 0.032 137.9 ± 3.2 134.5 ± 3.7 −3.4 (−5.2, −1.6) .000***
Quality of life
SF-36 total 419.3 ± 112.4 409.8 ± 87.5 414.6 ± 116.8 0.764 530.1 ± 95.6 637.2 ± 58.2 107.1 (65.6, 148.1) .000***
MH 48.1 ± 17.3 49.9 ± 17.6 46.1 ± 17.0 0.416 63.9 ± 16.6 69.9 ± 13.0 6.0 (−1.9, 13.9) 0.133
RE 46.6 ± 25.7 43.3 ± 27.9 50.0 ± 23.2 0.328 62.2 ± 24.4 77.4 ± 15.8 15.2 (4.3, 26.1) .007**
PF 48.8 ± 12.6 49.7 ± 12.7 47.9 ± 12.6 0.588 61.5 ± 13.3 79.0 ± 13.8 17.4 (10.3, 24.6) .000***
RP 47.8 ± 27.0 47.5 ± 28.1 48.2 ± 26.3 0.921 61.7 ± 26.9 81.2 ± 14.6 19.6 (8.2, 30.9) .001**
BP 55.2 ± 20.0 55.2 ± 22.0 55.1 ± 17.9 0.974 68.6 ± 20.7 82.0 ± 12.8 13.3 (4.3, 22.3) .000***
SF 60.3 ± 15.4 57.5 ± 14.2 63.4 ± 16.3 0.146 70.8 ± 13.7 87.1 ± 8.7 16.2 (10.2, 22.2) .000***
VT 57.7 ± 18.9 61.7 ± 18.0 53.4 ± 19.2 0.096 76.7 ± 15.1 80.4 ± 11.5 3.7 (−3.4, 10.8) 0.303
GH 54.8 ± 19.2 58.8 ± 16.7 50.5 ± 21.1 0.101 64.7 ± 18.2 80.4 ± 10.8 15.7 (7.9, 23.5) .000***
Obese (N, %)
hypertension (N, %) 21 (70) 16 (57.1) 21 (70) 9 (32.1)
hypertriglyceridemia 13 (43.3) 19 (67.9) 10 (33.3) 2 (7.1)
(N, %) 4 (13.3) 3 (10.7) 2 (6.7) 0 (0)
Note: Continuous variables are summarized by mean ± SD. Categorical variables are reported as N (%).*** significantly different (P < 0.001). ** significantly
different (P < 0.01)
Abbreviations: WC waist circumference, TG fasting serum-triglycerides, RSBP resting systolic blood tension, SF social functioning, MH mental health, RE role-emotional,
PF physical functioning, RP role –physical, BP bodily pain, VT vitality, GH general health
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considered the psycho-social factors and life qualities’
subjective evaluation in CMS patients.
We used the conceptual framework and methodology
described by the 2005 IDF (international diabetes foun-
dation) recommendations. For a Chinese patient to be
classified as “recovered”, they must meet the following
criteria: waist circumference < 90 cm for males and <
80 cm for females. If a person experienced clinically sig-
nificant change, but failed to meet the established cri-
teria for normal function, they are considered “improved
but not recovered” [47]. Our study shows that the mean
waist circumference of women post-intervention was
84.5 ± 1.6 cm while the pre- intervention mean was
92.0 ± 2.3 cm, which is considered “improved but not
recovered”.
For patients with non-communicable disease, the usual
treatment is pharmacological intervention. However, evi-
dences have shown that these patients should take more
responsibility for their health [48], and be more con-
scious about their healthy lifestyle, which can be crucial
for the success of their disease management. Behavior
patterns represent the single most prominent domain of
influence in public health [49]. However, unhealthy be-
havior is often enjoyable, hard to resist. Furthermore,
there is a weak connection between various types of
beneficial behavioral practices. For example, a man who
often exercises may still smoke. Patient-centered self-
management is the centerpiece of behavioral interven-
tion programs.
Psychology, self-monitoring and lifestyle behavioral in-
terventions rarely alleviate CMS in the long-term, with
many patients regaining these symptoms after therapy
[50]. It is very likely that such interventions come from
consultants’ suggestions rather than from patients’ inner
motivation. And it produces a rapid effect on the cardio-
metabolic syndrome that is gradually lost in the longer
term. There is a consensus to control these chronic dis-
eases by primarily adjusting patients’ behavior and life-
style, rather than using a pure biomedical approach [51].
For patients, learning the knowledge of good lifestyle
practices is not enough to ensure that positive choices are
made. Our intervention was developed based on the prem-
ise that a therapy approach based on self-motivation,
cognitive changes that leads to behavior change and the
practice of a “healthy lifestyle”, could offer more sustain-
able long-term benefit.
This patient-centered intervention, based on the
shared-decision-making and self-management, empha-
sizes the importance of flexibility in the way that physi-
cians structure the decision-making process so that
individual differences on their goals and preferences can
be respected. This research showed PC-CBT lifestyle
intervention reduced CMS symptoms as we hypothe-
sized. Changing the health behaviors of chronic patients
is difficult, it is therefore necessary to conduct more
patient-centered therapy.
Limitations
A significant association between self-determination be-
havior and healthy lifestyle on the reduction of CMS risk
was consistently found in this study. One limitation of
our study was the reliance on the self-reported quantita-
tive index, which is a subjective evaluation about their
quality of life. Furthermore, our sample size was deter-
mined by the recruitment conditions in this specific
Fig. 3 Mean Waist circumference (WC) of women between
two groups







F P-Value B Lower Upper
WC total a 35.960 0.000 0.535 0.357 0.714
TG (mmol/L) b 18.925 0.000 0.378 0.204 0.552
RSBP (mmHg) c 33.888 0.000 0.647 0.424 0.869
SF-36 total d 157.932 0.000 0.607 0.510 0.703
Note: Age, education were examined separately and were not significant
a: Independent variable: pre WC
b: Independent variable: pre TG
c: Independent variable: pre RSBP
d: Independent variable: pre SF-36 total
GLM general linear model
WC waist circumference
TG fasting serum-triglycerides
RSBP resting systolic blood tension
SF social functioning
Fig. 2 Mean Waist circumference (WC) of men between two groups
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patient population, the sample size was small and partic-
ipants randomized for the intervention research.
So the results may not be generalizable to other CMS pa-
tients. While cognitive behavioral treatment and patients-
centeredness are time-consuming, this study demonstrates
that PC-CBT lifestyle intervention has a positive effect in
promoting the CMS patients’ physical, psychological, and
social functions within a short time. Longer-term studies
are required to monitor if these changes are maintained.
Conclusion
It confirmed that active training in healthy psychological
and behavioral intensification is more effective than passive
provision of guidelines. Such interventions should include
patients-centeredness, emotional attention, cognitive ad-
justment, perceived social support and behavior intensifica-
tion techniques. Continued clinical follow up may be
required to further investigate for long-term maintenance
in individuals attempting psychological and behavioral life-
style change. The improved combination of psychological
and behavioral approaches with counseling should be fur-
ther investigated in a home-based model.
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